期刊文献+

FOXM1转录活性的调控及其与肿瘤的关系 被引量:1

Regulation of the FOXM1 transcription activity and its relationship with tumor
原文传递
导出
摘要 FOXM1属于FOX基因家族,仅特异性表达于增殖期细胞中。FOXM1可被多因子、多细胞信号通路共同参与的复杂过程激活,且其转录活性在细胞周期进展过程中逐渐增加。FOXM1在许多恶性肿瘤和肿瘤细胞株中均有表达,是肿瘤增殖所必需的转录因子,是临床上肿瘤治疗的新靶点。 FOXM1 is a member of the FOX gene family, and is specifically expressed in proliferating cells. Its transcription activity is activated by complicated process involving in multi-factor and multi-cell signaling pathways and is elevated during cell cycle progression. FOXM1 is found to be expressed in varieties of malignant tumors and tumor cell lines. Being an essential transcription factor for tumor proliferation, FOXM1 is considerd to be a potential new target for tumor therapy.
出处 《国际肿瘤学杂志》 CAS 2009年第10期736-738,共3页 Journal of International Oncology
关键词 细胞周期 肿瘤 FOXM1 Cell cycle Neoplasms FOXM1
  • 相关文献

参考文献22

  • 1Myatt SS, Lam EW. The emerging roles of forkhead box(Fox) proteins in cancer. Nat Rev Cancer, 2007, 7 (11 ) :847-859.
  • 2Ma RY, Tong TH, Cheung AM, et al. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXMIc. J Cell Sci, 2005, 118(4) :795-806.
  • 3Calvisi DF, Pinna F, Meloni F, et al. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma. Cancer Res, 2008, 68( 11 ) :4192-4200.
  • 4Wang IC, Chen YJ, Hughes D, et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF( Skp2-Cks1 ) ubiquitin ligase. Mol Cell Biol, 2005, 25 ( 24 ) : 10875-10894.
  • 5Ruiz i Ahaba A, Paima V, Dahmane N. Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci, 2002, 3( 1 ) :24-33.
  • 6Laoukili J, Kooistra MR, Bras A, et al. FoxMl is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol, 2005, 7(2) :126-136.
  • 7Calvisi DF, Pinna F, Ladu S, et al. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut, 2009, 58(5 ) :679-687.
  • 8Wierstra I, Alves J. FOXMIc is activated by cyelin E/Cdk2, cyelin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3alpha. Biochem Biophys Res Commun, 2006, 348 ( 1 ) :99-108.
  • 9Gusarova GA, Wang IC, Major ML, et al. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. J Clin Invest, 2007, 117(1) :99-111.
  • 10Kalinichenko VV, Major ML, Wang X, et al. Foxml b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev, 2004, 18(7) :830-850.

同被引文献13

  • 1Adamii GR, Ye H. Future roles for Foxml inhibitors in cancer treatments[J].Future Oneol, 2007,3 (1) : 1-3.
  • 2Koo CY, Muir KW,Lam EW. FOXM1 : From cancer initi- ation to progression and treatment [J].Biochim Biophys Acta, 2012,1819 (1) : 28-:37.
  • 3Teh MT, Wong ST, Neill GW, et al. Foxml is a down- stream target of Glil in basal cell carcinomas[J]. Cancer Res, 2002,62 (16) : 4773-4780.
  • 4Myatt SS, Lam EW. The emerging roles of forkhead box(Fox) proteins in cancer[J]. Nat Rev Cancer, 2007, 7 (11) :847-859.
  • 5Carter SL, Eklund AC, Kohane IS, et al. A signature of chromosomal instability inferred From gene expression profiles predicts clinical outcome in multiple human canc- ers[J]. Nat Genet,2006,38(9) :1043-1048.
  • 6Yeshida Y,Wang IC,Yoder HM,et al. The Forkhead Box M1 transcription factor contributes to the development and growth of mouse colorectal cancer[J]. Gastroenterol- ogy,2007,132(4) : 1420-1431.
  • 7Liu P,Cheng H, Roberts TM, et al. Targeting the phos- phoinositide 3-kinase pathway in cancer[J]. Nat Rev Drug Discov, 2009,8(8) : 627-644.
  • 8Penzo M, Massa PE, Olivotto E, et al. Sustained NF-kap- paB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or Foxml[J]. J Cell Physi- ol,2009,218(1) :215-227.
  • 9Francis RE, Myatt SS, Krol J, et al. Foxml is a down- stream target and marker of HER2 overexpression in breast cancer[J]. Int J Oncol, 2009,35 (1) : 57-68.
  • 10Nicolaou KC, Zak M, Rahimipour S, et al. Discovery of a biologically active thiostrepton fragment[J]. J Am Chem Soc, 2005,127(43) : 15042-15044.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部